Gild
1 known investors
Gilead is a biopharmaceutical company that develops and markets medicines across virology, oncology, and inflammation, with more than 25 medicines offered globally and a clinical pipeline of 53 programs. It also funds philanthropic HIV programs in the U.S.
BiotechHealthtech